SK Bioscience Co Ltd (302440) — Cash Flow Quality Index
SK Bioscience Co Ltd (302440) has a Cash Flow Quality Index of 0.84x as of September 2025. Operating cash flow of ₩20.65 Billion is below net income of ₩24.48 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does SK Bioscience Co Ltd generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SK Bioscience Co Ltd Cash Flow Quality Index (2018–2023)
Historical Cash Flow Quality Index for SK Bioscience Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of SK Bioscience Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for SK Bioscience Co Ltd (2018–2023)
Year-by-year earnings quality comparison for SK Bioscience Co Ltd. For live market cap and the full company financial profile, see market value of SK Bioscience Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.31x | ₩29.35 Billion | ₩22.32 Billion | ▲ +228.9% |
| 2022 | -1.02x | ₩-124.96 Billion | ₩122.45 Billion | ▼ -167.5% |
| 2021 | 1.51x | ₩536.59 Billion | ₩355.14 Billion | ▼ -58.7% |
| 2020 | 3.66x | ₩120.22 Billion | ₩32.89 Billion | ▲ +200.0% |
| 2019 | 1.22x | ₩21.82 Billion | ₩17.91 Billion | ▼ -96.6% |
| 2018 | 35.41x | ₩14.90 Billion | ₩420.84 Million | — |